ISPOR Europe Conference 2019
This week, Directors Brett Gardiner and Rachel Howard attended the ISPOR Europe conference in Copenhagen, Denmark
On November 4th to 6th, Directors Brett Gardiner and Rachel Howard joined 5,500 other healthcare leaders in attending the ISPOR Europe 2019 conference in Copenhagen, Denmark. The conference opened with an announcement that four Nordic countries have pledged to spend 5% of their GDP on preventive healthcare by 2030, a significant investment in the health of these Nations. This was a timely announcement given the three-day program of events centered around the theme of ‘Digital Transformation of Healthcare’.
Webcast: Portfolio analysis - Tracking for success
Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. As pharmaceutical companies simultaneously develop and in-license multiple products that can cost millions of dollars, portfolio management is about selecting how to allocate resources and marketing efforts across multiple assets. This has significant impact on the bottom line.
Communication trends in Latin America: How pharma can utilise new and emerging digital platforms
Smartphones and digital technology have revolutionised the way we communicate with one another. Latin America, like other parts of the world, has been swift to embrace new and emerging digital applications, in particular WhatsApp, which has become an ubiquitous tool for people in both their personal lives and in business. As digital communication channels increase in popularity, it is important for the pharmaceutical industry to keep in step. Understanding how to leverage platforms like WhatsApp as both a means of generating customer insight and as a stakeholder engagement tool, will help pharma companies to have impact in this exciting and ever-changing region.
Preparing to launch a new asset and in need of demand assessment research? Download our pre-launch checklist
An accurate forecast of customer appeal and likely future behaviour is critical to launch. We work with you to answer key questions when designing an effective market research study. Our research will give you the inputs you need for an accurate forecast.
China: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.
With a population of 1.4 billion people China has always been an attractive prize to the pharmaceutical industry. However, China has historically been a tough market to crack and few multinational companies have seen a good return on their investment. But in 2019, the 70th anniversary of the communist party’s victory, the outlook has changed completely and now pharma is rushing to leverage the many opportunities that China offers.